Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects
- PMID: 6408411
Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects
Similar articles
-
Studies of selective and reversible monoamine oxidase inhibitors.J Clin Psychiatry. 1984 Jul;45(7 Pt 2):62-6. J Clin Psychiatry. 1984. PMID: 6429130 Clinical Trial.
-
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).J Neural Transm Suppl. 1998;52:39-48. doi: 10.1007/978-3-7091-6499-0_5. J Neural Transm Suppl. 1998. PMID: 9564606 Clinical Trial.
-
New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.J Clin Psychiatry. 1984 Jul;45(7 Pt 2):37-43. J Clin Psychiatry. 1984. PMID: 6735994
-
Monoamine oxidase inhibitors--current status.Isr J Psychiatry Relat Sci. 1983;20(3):254-71. Isr J Psychiatry Relat Sci. 1983. PMID: 6325369 Review. No abstract available.
-
Depression: the case for a monoamine deficiency.J Clin Psychiatry. 2000;61 Suppl 6:7-11. J Clin Psychiatry. 2000. PMID: 10775018 Review.
Cited by
-
Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin.J Neural Transm. 1985;61(3-4):265-70. doi: 10.1007/BF01251917. J Neural Transm. 1985. PMID: 2580945
-
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic amines.Psychopharmacology (Berl). 1989;99(2):252-6. doi: 10.1007/BF00442818. Psychopharmacology (Berl). 1989. PMID: 2508163 Clinical Trial.
-
Role of inflammatory cytokines in depression: Focus on interleukin-1β.Biomed Rep. 2017 Jan;6(1):15-20. doi: 10.3892/br.2016.807. Epub 2016 Nov 10. Biomed Rep. 2017. PMID: 28123701 Free PMC article.